- Home
- SPT vs TMDX Comparison
SPT vs TMDX Comparison
Compare SPT & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPT
- TMDX
- Stock Information
- Founded
- SPT 2010
- TMDX 1998
- Country
- SPT United States
- TMDX United States
- Employees
- SPT N/A
- TMDX N/A
- Industry
- SPT Computer Software: Prepackaged Software
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SPT Technology
- TMDX Health Care
- Exchange
- SPT Nasdaq
- TMDX Nasdaq
- Market Cap
- SPT 1.9B
- TMDX 2.1B
- IPO Year
- SPT 2019
- TMDX 2019
- Fundamental
- Price
- SPT $33.03
- TMDX $56.73
- Analyst Decision
- SPT Buy
- TMDX Buy
- Analyst Count
- SPT 15
- TMDX 11
- Target Price
- SPT $45.92
- TMDX $116.10
- AVG Volume (30 Days)
- SPT 497.9K
- TMDX 2.6M
- Earning Date
- SPT 02-25-2025
- TMDX 02-24-2025
- Dividend Yield
- SPT N/A
- TMDX N/A
- EPS Growth
- SPT N/A
- TMDX N/A
- EPS
- SPT N/A
- TMDX 0.94
- Revenue
- SPT $392,402,000.00
- TMDX $401,090,000.00
- Revenue This Year
- SPT $22.78
- TMDX $81.61
- Revenue Next Year
- SPT $14.58
- TMDX $22.52
- P/E Ratio
- SPT N/A
- TMDX $60.54
- Revenue Growth
- SPT 26.70
- TMDX 109.09
- 52 Week Low
- SPT $25.05
- TMDX $55.00
- 52 Week High
- SPT $68.41
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- SPT 57.88
- TMDX 35.29
- Support Level
- SPT $29.48
- TMDX $58.40
- Resistance Level
- SPT $33.38
- TMDX $67.80
- Average True Range (ATR)
- SPT 1.23
- TMDX 4.65
- MACD
- SPT 0.10
- TMDX -0.46
- Stochastic Oscillator
- SPT 88.53
- TMDX 6.32
About SPT Sprout Social Inc
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. The firm generates majority revenue from software subscriptions.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.